Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
43.58
0.00 (0.00%)
At close: Dec 10, 2025, 4:00 PM EST
43.11
-0.47 (-1.08%)
After-hours: Dec 10, 2025, 6:31 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $1.87 billion as of December 10, 2025. Its market cap has increased by 182.60% in one year.
Market Cap
1.87B
Enterprise Value
1.31B
1-Year Change
182.60%
Ranking
Category
Stock Price
$43.58
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $1.87B, an increase of 1,046.38%. That is a compound annual growth rate of 196.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 1.87B | 189.60% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |